Clincosm LogoSign in Get a demo

refractory aml

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

Not yet recruiting
  • AML, Adult
  • +4 more
  • Amiens, France
  • +19 more
Sep 1, 2023

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023

Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • (no location specified)
Feb 17, 2023

Relapsed Adult AML Trial in Germany (Venetoclax Oral Tablet)

Recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Venetoclax Oral Tablet
  • Augsburg, Germany
  • +11 more
Jan 11, 2023

Acute Myeloid Leukemia, Relapsed AML, Refractory AML Trial in Germany (GEM333)

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • Mannheim, Baden-Württemberg, Germany
  • +6 more
Sep 28, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Advanced Solid Tumor, Relapsed AML, Refractory AML Trial in Hong Kong (NEI-01)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Hong Kong, Hong Kong
    The University of Hong Kong Phase I Clinical Trials Centre
May 6, 2022

Relapsed AML, Refractory AML Trial in Tokyo (AC220)

Completed
  • Relapsed AML
  • Refractory AML
  • Tokyo, Japan
    (unnamed)
Feb 8, 2019